Search results
Replay wins IND clearance for PRAME T cell cancer therapy
Pharmaceutical Technology via Yahoo Finance· 4 days agoGenome writing company Replay Bio has had its investigational new drug (IND) application cleared by...
Revolutionizing Cancer Treatment: Key to Prolonging CAR T Cell Life Uncovered
SciTechDaily· 5 days agoFOXO1 is required for T cell memory and is linked to longer-lasting clinical outcomes in CAR T cell ...
Valley Children's Receives Historic $15 Million Gift to Create Advanced Cell Therapy Program for...
KOLR - KSFX Ozarks· 2 days agoValley Children's Healthcare this week announced a historic donation of $15 million that will significantly enhance the hospital's ability to provide the most advanced bone marrow transplant ...
Do cutting-edge CAR-T-cell therapies cause cancer? What the data say
Nature· 5 days agoRegulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is...
Newly discovered mechanism of T-cell control can interfere with cancer immunotherapies
Science Daily· 2 days agoThe T cells of the immune system are the main players in the defense against viral infections and tumor cells. The body must therefore keep a tight control on T cell ...
Cell and gene therapy companies trip at scalability hurdle
Pharmaceutical Technology via Yahoo Finance· 6 days agoSince then, major strides have been made in the cell therapy space. The first chimeric antigen...
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop...
WKRN Nashville· 3 days agoPoseida is advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases.
CD70 Antibodies CD70 Targeting Therapies Clinical Trials Market Opportunity Insight
Benzinga· 4 days agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70
New technique improves T cell-based immunotherapies for solid tumors
Medical Xpress· 3 days agoScientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate cancer—so T cells can ...
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma -...
Benzinga· 5 days agoNEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell